Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

At the end of October 2024, the world lost a founding father of modern Functional Neurosurgery – Professor Tipu Aziz.

Professor Tipu Aziz in the operating theatre with the text 'Tipu Aziz, Emeritus Professor of Neurosurgery & Founder and Former Head of Oxford Functional Neurosurgery'

Tipu was a revered and highly respected colleague in the Department of Neurosurgery at the Oxford University Hospitals NHS Foundation Trust and in the Nuffield Department of Surgical Sciences at the University of Oxford.

Having endured the civil war in Bangladesh during his childhood in the 1960s, he spent some time in the USA before studying for A-levels in the UK and initially took a degree in Neurophysiology. He later studied medicine and his research involved ground-breaking and seminal work on the Subthalamic Nucleus in Parkinson’s disease and undoubtedly was crucial in the subsequent rise of Deep Brain Stimulation (DBS) for movement disorders Internationally. He was world-renowned for his work which included not just pioneering clinical treatments such as DBS for chronic pain, but also Neuroscience, especially neurophysiology and the application of neuroimaging to DBS.

He published over 400 peer-reviewed articles and won a number of awards including the Society of British Neurological Surgeons’ lifetime achievement award. He was a true patient advocate and was loved by his patients for his dedication, down to earth manner, humour, and enthusiasm for making them better. He championed the use of animals in research, taking great personal risk but pursuing and adhering to what he perceived to be the right thing to do.

Read the full story on the Nuffield Department of Surgical Sciences website.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience